Disease 指定難病
疾患数 : 348 - 臨床試験総数 : 39,610 / 薬物総数 : 18,765 - ( DrugBank : 2,435 ) / 標的遺伝子総数 : 703 - 標的パスウェイ総数 : 305
告示 番号 | 疾患名 [疾患群] | 臨床試験数 | Phase 1 / 2 / 3 / 4 | 薬物数 [ DrugBank ] | 標的遺伝子数 | パスウェイ数 | 国内患者数 医療費受給者証所持者数 (R5年度) |
---|---|---|---|---|---|
40 | 高安動脈炎 [免] 💬 "Takayasu arteritis", "Aortitis syndrome", "Pulseless disease", "Aortitis syndrome" | 30 30 trials | 0 / 6 / 8 / 5 💬 | 41 41 drugs [ 22 22 drugs ] | 26 26 genes | 115 pathways | 4676 4,676人年齢分布
![]() |
41 | 巨細胞性動脈炎 [免] 💬 "Giant cell arteritis", "Temporal arteritis" | 154 154 trials | 5 / 38 / 83 / 7 💬 | 139 139 drugs [ 37 37 drugs ] | 33 33 genes | 125 pathways | 2853 2,853人年齢分布
![]() |
42 | 結節性多発動脈炎 [免] 💬 "Polyarteritis nodosa", "PAN" | 15 15 trials | 0 / 3 / 6 / 2 💬 | 22 22 drugs [ 16 16 drugs ] | 26 26 genes | 104 pathways | 2115 2,115人年齢分布
![]() |
43 | 顕微鏡的多発血管炎 [免] 💬 "Microscopic polyangiitis", "MPA" | 95 95 trials | 3 / 33 / 42 / 7 💬 | 65 65 drugs [ 23 23 drugs ] | 14 14 genes | 87 pathways | 11879 11,879人年齢分布
![]() |
44 | 多発血管炎性肉芽腫症 [免] 💬 "Wegener granulomatosis", "Multiple vasculitis granulomatous disease", "Granulomatosis with polyangiitis" | 122 122 trials | 1 / 10 / 45 / 3 💬 | 89 89 drugs [ 31 31 drugs ] | 23 23 genes | 81 pathways | 3537 3,537人年齢分布
![]() |
45 | 好酸球性多発血管炎性肉芽腫症 [免] 💬 "Eosinophilic granulomatosis with Polyangiitis", "EGPA", "Eosinophilic multiple vasculitis granulomatous disease", "Allergic granulomatous angiitis", "AGA", "Churg-Strauss syndrome", "CSS" | 45 45 trials | 2 / 5 / 1 / 1 💬 | 39 39 drugs [ 19 19 drugs ] | 19 19 genes | 100 pathways | 7643 7,643人年齢分布
![]() |
46 | 悪性関節リウマチ [免] 💬 "Malignant rheumatoid arthritis", "MRA", "Rheumatoid vasculitis", "RV", "Rheumatoid arthritis", "RA", "Systemic rheumatoid vasculitis", "SRV" | 4,543 4,543 trials | 358 / 917 / 1169 / 562 💬 | 2,251 2,251 drugs [ 390 390 drugs ] | 198 198 genes | 232 pathways | 4825 4,825人年齢分布
![]() |
48 | 原発性抗リン脂質抗体症候群 [免] 💬 "Primary antiphospholipid syndrome", "Primary antiphospholipid antibody syndrome", "Primary APS", "PAPS" | 9 9 trials | 1 / 5 / 1 / 0 💬 | 8 8 drugs [ 6 6 drugs ] | 3 3 genes | 59 pathways | 1174 1,174人年齢分布
![]() |
49 | 全身性エリテマトーデス [免] 💬 "Systemic lupus erythematosus", "SLE" | 1,227 1,227 trials | 200 / 425 / 303 / 78 💬 | 752 752 drugs [ 175 175 drugs ] | 130 130 genes | 207 pathways | 66307 66,307人年齢分布
![]() |
50 | 皮膚筋炎/多発性筋炎 [免] 💬 "Dermatomyositis", "Polymyositis" | 231 231 trials | 17 / 91 / 68 / 10 💬 | 216 216 drugs [ 55 55 drugs ] | 59 59 genes | 141 pathways | 26999 26,999人年齢分布
![]() |
51 | 全身性強皮症 [免] 💬 "Scleroderma", "Systemic sclerosis", "SSc", "Diffuse cutaneous SSc", "dcSSc", "Limited cutaneous SSc", "lcSSc" | 639 639 trials | 70 / 282 / 134 / 24 💬 | 551 551 drugs [ 157 157 drugs ] | 135 135 genes | 222 pathways | 27057 27,057人年齢分布
![]() |
52 | 混合性結合組織病 [免] 💬 "Mixed connective tissue disease" | 9 9 trials | 0 / 4 / 0 / 0 💬 | 8 8 drugs [ 4 4 drugs ] | 1 1 gene | 1 pathway | 10199 10,199人年齢分布
![]() |
53 | シェーグレン症候群 [免] 💬 "Sjogren syndrome", "Sjögren syndrome", "Syndrome Sjogren's", "Autoimmune exocrinopathy" | 368 368 trials | 30 / 181 / 56 / 23 💬 | 277 277 drugs [ 94 94 drugs ] | 62 62 genes | 186 pathways | 20476 20,476人年齢分布
![]() |
54 | 成人発症スチル病 [免] 💬 "Adult still disease", "Adult-onset Still's disease" | 25 25 trials | 1 / 9 / 5 / 0 💬 | 32 32 drugs [ 16 16 drugs ] | 16 16 genes | 99 pathways | 4705 4,705人年齢分布
![]() |
55 | 再発性多発軟骨炎 [免] 💬 "Relapsing polychondritis" | 10 10 trials | 2 / 4 / 0 / 0 💬 | 14 14 drugs [ 12 12 drugs ] | 14 14 genes | 111 pathways | 1083 1,083人年齢分布
![]() |
56 | ベーチェット病 [免] 💬 "Behcet disease", "Behçet disease", "BD" | 87 87 trials | 5 / 21 / 30 / 5 💬 | 90 90 drugs [ 35 35 drugs ] | 41 41 genes | 126 pathways | 15164 15,164人年齢分布
![]() |
106 | クリオピリン関連周期熱症候群 [免] 💬 "Cryopyrin-associated periodic syndrome", "Cryopyrin associated periodic fever syndrome", "Familial cold autoinflammatory syndrome", "FCAS", "Muckle-Wells syndrome", "MWS", "Chronic infantile neurologic cutaneous, and articular syndrome", "CINCA syndrome", "Neonatal onset multisystem inflammatory disease", "NOMID" | 56 56 trials | 3 / 10 / 16 / 0 💬 | 27 27 drugs [ 7 7 drugs ] | 4 4 genes | 47 pathways | 95 95人年齢分布
![]() |
107 | 若年性特発性関節炎 [免] 💬 "Juvenile idiopathic arthritis", "JIA", "Systemic juvenile idiopathic arthritis", "Systemic-onset juvenile idiopathic arthritis", "sJIA", "Joint-type juvenile idiopathic arthritis", "Joint-type juvenile idiopathic arthritis", "Joint-type JIA" | 477 477 trials | 43 / 60 / 193 / 40 💬 | 232 232 drugs [ 53 53 drugs ] | 66 66 genes | 160 pathways | 1195 1,195人年齢分布
![]() |
108 | TNF受容体関連周期性症候群 [免] 💬 "TNF receptor-associated periodic syndrome" | 5 5 trials | 0 / 1 / 1 / 0 💬 | 5 5 drugs [ 1 1 drug ] | 1 1 gene | 43 pathways | 34 34人年齢分布
![]() |
110 | ブラウ症候群 [免] 💬 "Blau syndrome", "Early-onset sarcoidosis", "Systemic granulomatous diseases", "Systemic inflammatory granulomatous disease", "Juvenile onset sarcoidosis", "Early-onset childhood sarcoidosis", "Childhood sarcoidosis", "Early onset sarcoidosis", "EOS" | 3 3 trials | 0 / 0 / 0 / 1 💬 | 3 3 drugs [ 1 1 drug ] | 4 4 genes | 39 pathways | 24 24人年齢分布
![]() |
266 | 家族性地中海熱 [免] 💬 "Familial mediterranean fever" | 35 35 trials | 1 / 10 / 10 / 3 💬 | 21 21 drugs [ 7 7 drugs ] | 14 14 genes | 58 pathways | 786 786人年齢分布
![]() |
267 | 高IgD症候群 [免] 💬 "Hyper-IgD syndrome", "HIDS", "Mevalonate kinase deffiency", "Hyperimmunoglobulinemia D and periodic fever syndrome" | 12 12 trials | 0 / 2 / 0 / 0 💬 | 5 5 drugs [ 1 1 drug ] | 1 1 gene | 43 pathways | 3 3人年齢分布
![]() |
268 | 中條・西村症候群 [免] 💬 "Nakajo-Nishimura syndrome", "Autoinflammation, lipodystrophy, and dermatosis syndrome", "CANDLE syndrome", "JMP syndrome", "Nakajo syndrome" | 2 2 trials | 0 / 0 / 0 / 0 💬 | 3 3 drugs [ 1 1 drug ] | 2 2 genes | 37 pathways | 9 9人年齢分布
![]() |
269 | 化膿性無菌性関節炎・壊疽性膿皮症・アクネ症候群 [免] 💬 "Pyogenic arthritis", "Pyoderma gangrenosum", "Acne syndrome", "PAPA syndrome" | 32 32 trials | 1 / 16 / 10 / 2 💬 | 32 32 drugs [ 16 16 drugs ] | 17 17 genes | 106 pathways | 14 14人年齢分布
![]() |
300 | IgG4関連疾患 [免] 💬 "IgG4-related disease", "IgG4-related disease", "Autoimmune pancreatitis", "IgG4-related sclerosing cholangitis", "IgG4-related lacrimal gland, orbital, and salivary gland lesions", "IgG4-related kidney disease" | 57 57 trials | 2 / 12 / 17 / 7 💬 | 52 52 drugs [ 29 29 drugs ] | 20 20 genes | 147 pathways | 4120 4,120人年齢分布
![]() |
306 | 好酸球性副鼻腔炎 [免] 💬 [聴] 💬 "Eosinophilic sinusitis" | 1 1 trial | 0 / 0 / 0 / 0 💬 | 2 2 drugs [ 3 3 drugs ] | 2 2 genes | 11 pathways | 28491 28,491人年齢分布
![]() |
325 | 遺伝性自己炎症疾患 [免] 💬 "Hereditary autoinflammatory syndrome", "NLRC4 abnormality", "Adenosine deaminase 2 deficiency", "ADA2 deficiency", "DADA2", "Aicardi-Goutieres syndrome", "AGS", "A20 haploinsufficiency", "HA20" | 12 12 trials | 1 / 7 / 0 / 0 💬 | 15 15 drugs [ 7 7 drugs ] | 2 2 genes | 37 pathways | 20 20人年齢分布
![]() |
345 | 乳児発症STING関連血管炎 [免] 💬 [染] 💬 "Stimulator of interferon genes(STING)-associated vasculopathy with onset in infancy", "STING (stimulator of interferon genes)-associated vasculopathy with onset in infancy", "STING-associated vasculopathy with onset in infancy", "SAVI" | 5 5 trials | 0 / 1 / 1 / 0 💬 | 3 3 drugs [ 1 1 drug ] | 2 2 genes | 37 pathways | - |